Cargando…
Metabolomics and random forests in patients with complex congenital heart disease
INTRODUCTION: It is increasingly common to simultaneously determine a large number of metabolites in order to assess the metabolic state of, or clarify biochemical pathways in, an organism (“metabolomics”). This approach is increasingly used in the investigation of the development of heart failure....
Autores principales: | Michel, Miriam, Laser, Kai Thorsten, Dubowy, Karl-Otto, Scholl-Bürgi, Sabine, Michel, Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581308/ https://www.ncbi.nlm.nih.gov/pubmed/36277761 http://dx.doi.org/10.3389/fcvm.2022.994068 |
Ejemplares similares
-
Method comparison of HPLC-ninhydrin-photometry and UHPLC-PITC-tandem mass spectrometry for serum amino acid analyses in patients with complex congenital heart disease and controls
por: Michel, Miriam, et al.
Publicado: (2020) -
Targeted metabolomic analysis of serum phospholipid and acylcarnitine in the adult Fontan patient with a dominant left ventricle
por: Michel, Miriam, et al.
Publicado: (2020) -
Targeted metabolomic analysis of serum amino acids in the adult Fontan patient with a dominant left ventricle
por: Michel, Miriam, et al.
Publicado: (2020) -
Analysis of Biomarkers for Congenital Heart Disease Based on Maternal Amniotic Fluid Metabolomics
por: Li, Yahong, et al.
Publicado: (2021) -
Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy
por: Renaud, David, et al.
Publicado: (2023)